Kearney M - Search Results

1

Evaluating Real-World Characteristics of Patients With Advanced Urothelial Carcinoma Eligible for Avelumab Maintenance Therapy: A Multicountry Retrospective Medical Chart Review.

Bellmunt J, Chang J, Pavilack-Kirker M, Cappelleri JC, Costa N, Esterberg E, Kearney M, Hitchens A, Candrilli SD, Ajmera M. Bellmunt J, et al. Among authors: kearney m. Clin Genitourin Cancer. 2023 Aug;21(4):459-466. doi: 10.1016/j.clgc.2023.03.011. Epub 2023 Mar 31. Clin Genitourin Cancer. 2023. PMID: 37149458

2

Physician reported treatment patterns and outcomes in metastatic bladder cancer in the USA: the CancerMPact^® Survey 2020.

Bueno APA, Clark O, Turnure M, Moreira ES, Chang J, Hou N, Li S, Kim R, Kearney M, Kirker M, Kanas G. Bueno APA, et al. Among authors: kearney m. Future Oncol. 2024 Mar;20(10):613-622. doi: 10.2217/fon-2022-1066. Epub 2023 Jun 26. Future Oncol. 2024. PMID: 37357780 Free article.

3

Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.

Critchlow S, Bullement A, Crabb S, Jones R, Christoforou K, Amin A, Xiao Y, Kapetanakis V, Benedict Á, Chang J, Kearney M, Eccleston A. Critchlow S, et al. Among authors: kearney m. Future Oncol. 2024 Mar;20(8):459-470. doi: 10.2217/fon-2023-0372. Epub 2023 Aug 2. Future Oncol. 2024. PMID: 37529943 Free article.

4

A cost-effectiveness analysis of avelumab plus best supportive care versus best supportive care alone as first-line maintenance treatment for patients with locally advanced or metastatic urothelial carcinoma in Taiwan.

Su PJ, Xiao Y, Lin AY, Goh C, Wu E, Liu K, Chou P, Kuo K, Palencia R, Chang J, Kearney M, Kapetanakis V, Benedict A. Su PJ, et al. Among authors: kearney m. Cancer Rep (Hoboken). 2023 Oct;6(10):e1887. doi: 10.1002/cnr2.1887. Epub 2023 Aug 28. Cancer Rep (Hoboken). 2023. PMID: 37640556 Free PMC article.

5

Real-World Analysis of Treatment Patterns and Platinum-Based Treatment Eligibility of Patients With Metastatic Urothelial Cancer in 5 European Countries.

Milloy N, Kirker M, Unsworth M, Montgomery R, Kluth C, Kearney M, Chang J. Milloy N, et al. Among authors: kearney m. Clin Genitourin Cancer. 2024 Feb;22(1):e136-e147.e1. doi: 10.1016/j.clgc.2023.09.010. Epub 2023 Oct 2. Clin Genitourin Cancer. 2024. PMID: 37945404 Free article.

6

Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact^® survey 2020.

A Bueno AP, Clark O, Turnure M, Moreira ES, Yuasa A, Sugiyama S, Kirker M, Li S, Hou N, Chang J, Kearney M, Kanas G. A Bueno AP, et al. Among authors: kearney m. Future Oncol. 2024 Mar;20(10):603-611. doi: 10.2217/fon-2023-0197. Epub 2024 Jan 12. Future Oncol. 2024. PMID: 38214131 Free article.

7

Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.

Porte F, Granghaud A, Chang J, Kearney M, Morel A, Plessala I, Cawston H, Roiz J, Xiao Y, Solbes MN, Lambert P, Ravaud A, Loriot Y, Thiery-Vuillemin A, Lévy P. Porte F, et al. Among authors: kearney m. PLoS One. 2024 May 10;19(5):e0302548. doi: 10.1371/journal.pone.0302548. eCollection 2024. PLoS One. 2024. PMID: 38728337 Free PMC article.

8

Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis.

O'Dwyer R, Musat MG, Gulas I, Hubscher E, Moradian H, Guenther S, Kearney M, Sridhar SS. O'Dwyer R, et al. Among authors: kearney m. Clin Genitourin Cancer. 2024 Dec;22(6):102176. doi: 10.1016/j.clgc.2024.102176. Epub 2024 Jul 25. Clin Genitourin Cancer. 2024. PMID: 39260094 Free article.

9

Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States.

Moon HH, Kearney M, Mahmoudpour SH, Ike C, Morris V, Rava A, Kim S, Sun H, Boyd M, Gomez Rey G. Moon HH, et al. Among authors: kearney m. Curr Oncol. 2024 Sep 21;31(9):5662-5676. doi: 10.3390/curroncol31090420. Curr Oncol. 2024. PMID: 39330048 Free PMC article.

10

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US.

Bharmal M, Kearney M, Zheng Y, Phatak H. Bharmal M, et al. Among authors: kearney m. Clinicoecon Outcomes Res. 2019 May 22;11:349-359. doi: 10.2147/CEOR.S202642. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31190927 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,078 results

Search Page

Filters